Clinical Trial Update: Transanal Resection of Rectal Lesions With the ColubrisMX ELS System [NA]

View source ↗

Summary

The clinical trial NCT04651764 evaluating transanal resection of rectal lesions using the ColubrisMX ELS System has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenoma
• Rectal Lesion
• Rectal Polyp

Drugs mentioned

• ColubrisMX ELS System

Snippet

Sponsor: ColubrisMX | Conditions: Rectal Adenoma, Rectal Polyp | NA | Status: TERMINATED